MiniJect delivers high viscosity formulations.. Expands range of injectable therapies, especially in regenerative ...
Kaléo today announced that it has entered into a confidential license agreement with Amgen Inc. Under the terms of the agreement, Amgen obtained a license to certain of Kaléo's patented technology on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results